Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-26-054113
Filing Date
2026-05-01
Accepted
2026-05-01 16:05:29
Documents
21

Document Format Files

Seq Description Document Type Size
1 S-3 tm2613101-1_s3.htm S-3 587294
2 EXHIBIT 1.2 tm2613101d2_ex1-2.htm EX-1.2 256833
3 EXHIBIT 4.2 tm2613101d2_ex4-2.htm EX-4.2 383399
4 EXHIBIT 4.4 tm2613101d2_ex4-4.htm EX-4.4 113852
5 EXHIBIT 4.5 tm2613101d2_ex4-5.htm EX-4.5 119541
6 EXHIBIT 4.6 tm2613101d2_ex4-6.htm EX-4.6 106762
7 EXHIBIT 5.1 tm2613101d2_ex5-1.htm EX-5.1 33609
8 EXHIBIT 23.1 tm2613101d2_ex23-1.htm EX-23.1 3084
9 EX-FILING FEES tm2613101d1_ex-filingfees.htm   iXBRL EX-FILING FEES 34428
10 GRAPHIC lg_tvardi-4c.jpg GRAPHIC 15572
11 GRAPHIC tb_pipeline-4c.jpg GRAPHIC 52882
12 GRAPHIC tm2613101d2_ex5-1img01.jpg GRAPHIC 10100
  Complete submission text file 0001104659-26-054113.txt   1881836

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2613101d1_ex-filingfees_htm.xml XML 9542
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-295496 | Film No.: 26932429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)